Eagle Pharmaceuticals Announces FDA Accepts RTU Bivalirudin NDA for Filing
July 23, 2015 at 07:10 AM EDT
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced that the 505(b)(2) New Drug Application (NDA) for its novel ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.